Raymond James initiated coverage of Alnylam with an Outperform rating and $208 price target.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ALNY:
- Alnylam should be bought on recent selloff, says H.C. Wainwright
- Concerns over label expansion for Alnylam overdone, says Citi
- Barclays sees FDA panel vote as ‘clear win’ for Alnylam
- Alnylam (NASDAQ:ALNY) Stock Down Despite a Positive Development
- Alnylam announces positive outcome of FDA AdCom meeting on Patisiran